Despite research into a male contraceptive pill starting around the same time as its female counterpart, no product has ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample speaks to bioethicist Prof Lisa Campo-Engelstein of the University of Texas and Prof Chris Barratt from the University of Dundee about why male contraceptives have been so difficult to develop, and what kind of options are in the pipeline
About Author
More Stories
Exercise ‘better than drugs’ to stop cancer returning after treatment, trial finds
New AI test can predict which men will benefit from prostate cancer drug
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip